Blood News and Research

RSS

EKF Diagnostics introduces new version of Lactate Scout+ analyzer

EKF Diagnostics, the global diagnostics business, announces the launch of the new version of its Lactate Scout+ analyzer.

From EKF Diagnostics 20 Nov 2013

DNA vaccine demonstrates potential to prevent and treat deadly MERS coronavirus

Inovio Pharmaceuticals, Inc. announced today that preclinical testing of a DNA synthetic vaccine for the virulent Middle East Respiratory Syndrome coronavirus (MERS) induced robust and durable immune responses, demonstrating the potential for a SynCon DNA vaccine to prevent and treat this deadly virus.

20 Nov 2013

Staphylococcus Aureus Bacteria anticipates and turns immune defenses against the host

Around 20 percent of all humans are persistently colonized with Staphylococcus aureus bacteria, a leading cause of skin infections and one of the major sources of hospital-acquired infections, including the antibiotic-resistant strain MRSA.

20 Nov 2013

Vect-Horus, AAA form scientific collaboration to open new avenues in treatment of brain diseases

Vect-Horus, a French company specialized in the development of vector molecules for the central nervous system, announces today it has signed a scientific collaboration agreement with Advanced Accelerator Applications, a fast growing international player in Molecular Nuclear Medicine. The financial terms of the deal have not been disclosed.

20 Nov 2013

NeutroPhase irrigation therapy and NPWT help treat severe flesh eating and wound infections

NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing topical non-antibiotic antimicrobial products, today announced the publication of a scientific paper by Dr. John R. Crew of Seton Medical Center, Daly City, California, describing the first use of adjunctive NeutroPhase irrigation therapy in conjunction with Negative Pressure Wound Therapy to successfully manage the severely-infected wound in the arm of a patient with life-threatening 'flesh-eating' disease.

20 Nov 2013

Simple blood test may predict people at highest risk for developing heart problems

For years, doctors have been divided on how effective annual testing and screenings are for apparently healthy individuals. New research, however, shows that a simple blood test may predict who is at highest risk to develop heart problems - and how long these people may have to live.

20 Nov 2013

Findings could potentially save millions of people from having unnecessary cardiac catheterization

An ultrafast, 320-detector computed tomography scanner that shows both anatomy within coronary arteries and blood flow can accurately sort out which people need - or don't need - an invasive procedure to identify coronary blockages, according to an international study. The researchers say their findings could potentially save millions of people worldwide from having an unnecessary cardiac catheterization.

20 Nov 2013

Findings underscore importance of obesity prevention and nutrition in addressing metabolic syndrome

Data reported by the Hearts Beat Back: The Heart of New Ulm Project reinforce the positive influence of lifestyle factors in mitigating risks that potentially increase the likelihood of heart disease and other health problems. Findings based on 1,059 residents of New Ulm, Minn, underscore the importance of obesity prevention and nutrition, specifically eating more fruits and vegetables, in addressing metabolic syndrome, a common precursor to cardiovascular disease.

20 Nov 2013

Research provides first rigorous comparison of 2 surgical approaches for severe heart valve disease

New research presented today at the 2013 Scientific Sessions of the American Heart Association by researchers at the Perelman School of Medicine at the University of Pennsylvaniafound no difference in outcomes at one-year between two recommended surgical options for treating ischemic mitral regurgitation (IMR) - repair of the leaky valve or its replacement with an artificial valve.

20 Nov 2013

Youth prefer rapid point-of-care HIV tests than traditional blood tests

Youth prefer, accept and receive HIV results more often when offered rapid finger prick or saliva swab tests rather than traditional blood tests according to a study by researchers at St. Michael's Hospital.

20 Nov 2013

Adding corticosteroid fluocortolone with standard therapy improves visual acuity in NAION patients

Nonarteritic anterior ischemic optic neuropathy is one of the leading causes of sudden and irreversible loss of vision in older adults. In a prospective randomized trial of 60 patients with NAION, investigators have shown that the addition of the corticosteroid fluocortolone to standard therapy significantly improves both short- and long-term visual acuity, especially when given soon after the onset of symptoms. Their results are published in Restorative Neurology and Neuroscience.

20 Nov 2013

Gene-based method for selecting doses of warfarin no better than standardized dosing methods

A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has determined that a gene-based method for selecting patients' doses of the popular heart medication warfarin is no better than standardized dosing methods. The study was presented today at the 2013 Scientific Sessions of the American Heart Association and published simultaneously in the New England Journal of Medicine.

20 Nov 2013

Tasquinimod drug effective for men with metastatic castration-resistant prostate cancer

An investigational prostate cancer treatment slows the disease's progression and may increase survival, especially among men whose cancer has spread to the bones, according an analysis led by the Duke Cancer Institute.

20 Nov 2013

LabStyle Innovations, InnoMed ink distribution agreement for Dario blood glucose monitoring device

LabStyle Innovations Corp., developer of Dario, a cloud-based, mobile health platform for diabetes and related blood glucose monitoring, announced today that it has entered into an exclusive agreement with InnoMed Ltd. to distribute the Dario diabetes management platform's blood glucose monitoring device in New Zealand. The terms of the agreement were not disclosed.

20 Nov 2013

New biomarker predicts that concussion victims may have cognitive dysfunction following mTBI

A new blood biomarker correctly predicted which concussion victims went on to have white matter tract structural damage and persistent cognitive dysfunction following a mild traumatic brain injury.

20 Nov 2013

Serametrix launches new MDSC-based blood test for cancer patients

Serametrix Corporation has announced the launch of an important new blood test for cancer patients. The test measures a patient's level of circulating Myeloid Derived Suppressor Cells (MDSCs) that are known to decrease anti-tumor immunity and are associated with poor survival rates in cancer patients.

20 Nov 2013

NSU researchers selected to participate in DoD Gulf War Illness Research Program Consortium

Nova Southeastern University President and CEO George L. Hanbury II, Ph.D., recently announced that a NSU research team led by Mariana Morris, Ph.D., and Nancy Klimas, M.D., was selected by the U.S. Department of Defense as one of two DoD Gulf War Illness Research Program Consortium awardees.

20 Nov 2013

Once-daily edoxaban prevents stroke in patients with atrial fibrillation

According to the United States Centers for Disease Control and Prevention, over 800,000 Americans die each year from heart disease and stroke. Stroke is the leading cause of serious long-term disability and death in the US. In addition to lifestyle changes, medications such as anti-blood clotting drugs are helpful in the prevention of stroke.

20 Nov 2013

MICS CABG procedure safe and feasible, confirms new study

A new study published by The Journal of Thoracic and Cardiovascular Surgery confirms MICS CABG (minimally invasive cardiac surgery/coronary artery bypass grafting) is a safe and feasible procedure that ensures positive outcomes. Published on Nov 1st, the article brings light to the open-heart surgery alternative pioneered by Medical Director and cardiothoracic surgeon, Joseph T. McGinn of The Heart Institute at Staten Island University Hospital.

20 Nov 2013

Boston Scientific's Direxion Torqueable Microcatheter receives FDA clearance and CE Mark approval

Further bolstering its market-leading portfolio of peripheral embolization technologies, Boston Scientific Corporation has received U.S. Food and Drug Administration clearance and CE Mark approval for its Direxion Torqueable Microcatheter.

20 Nov 2013

Blood News and Research

EKF Diagnostics introduces new version of Lactate Scout+ analyzer

DNA vaccine demonstrates potential to prevent and treat deadly MERS coronavirus

Staphylococcus Aureus Bacteria anticipates and turns immune defenses against the host

Vect-Horus, AAA form scientific collaboration to open new avenues in treatment of brain diseases

NeutroPhase irrigation therapy and NPWT help treat severe flesh eating and wound infections

Simple blood test may predict people at highest risk for developing heart problems

Findings could potentially save millions of people from having unnecessary cardiac catheterization

Findings underscore importance of obesity prevention and nutrition in addressing metabolic syndrome

Research provides first rigorous comparison of 2 surgical approaches for severe heart valve disease

Youth prefer rapid point-of-care HIV tests than traditional blood tests

Adding corticosteroid fluocortolone with standard therapy improves visual acuity in NAION patients

Gene-based method for selecting doses of warfarin no better than standardized dosing methods

Tasquinimod drug effective for men with metastatic castration-resistant prostate cancer

LabStyle Innovations, InnoMed ink distribution agreement for Dario blood glucose monitoring device

New biomarker predicts that concussion victims may have cognitive dysfunction following mTBI

Serametrix launches new MDSC-based blood test for cancer patients

NSU researchers selected to participate in DoD Gulf War Illness Research Program Consortium

Once-daily edoxaban prevents stroke in patients with atrial fibrillation

MICS CABG procedure safe and feasible, confirms new study

Boston Scientific's Direxion Torqueable Microcatheter receives FDA clearance and CE Mark approval

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News